Shaily Engineering Plastics Ltd has entered into a four-year manufacturing and commercial supply agreement with a leading domestic pharmaceutical company. The ₹423 crore contract covers the supply of pen injectors, strengthening Shaily’s presence in India’s healthcare sector and reinforcing its expertise in precision-engineered medical devices.
Shaily Engineering Plastics Limited has announced the signing of a significant ₹423 crore contract with a large domestic pharma company. The agreement, disclosed under SEBI Regulation 30, involves the manufacturing and supply of pen injectors over a four-year period.
This deal marks a strategic milestone for Shaily, positioning the company as a key partner in India’s growing pharmaceutical and medical devices ecosystem. With rising demand for advanced drug delivery systems, Shaily’s expertise in engineering plastics ensures both innovation and reliability in healthcare solutions.
Key Highlights
-
Contract Value: Approx. ₹423 crores
-
Duration: 4 years supply agreement
-
Nature of Agreement: Manufacturing & Commercial Supply of pen injectors
-
Entity Awarding Contract: Large domestic pharma company (name undisclosed due to confidentiality)
-
Scope: Domestic market focus
-
Promoter Interest: None; not a related party transaction
This agreement underscores Shaily’s commitment to expanding its footprint in the healthcare sector while delivering high-quality, precision-engineered solutions to the pharmaceutical industry.
Source: Official filing by Shaily Engineering Plastics Limited to BSE Limited